PBMs negotiate drug prices and rebates with manufacturers for their employer and health plan customers. A Novo Nordisk ...

Nearly one-third of those patients were paying $35 or far more per month in 2019, according to the latest available data from ...

in the US for operating a "perverse drug rebate system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the FTC published a ...

A new ad playing on TV, endorsed by Kaine, says he worked to lower insulin prices. We verify that claim before Election Day.

INSULIN LITIGATION DEEP-DIVE — As Congress ... The counties say their contracts require that rebates the PBMs negotiate with manufacturers must “pass through” to them, which payers can ...

As far as the rebate eligibility problem is concerned ... for diabetics who aren't using insulin. And DexCom is building a ...

The Affordable Insulin Now Act, as it is known ... recently published its own research finding that rebates, discounts and other payments from pharma companies to pharmacy benefit managers ...

Choose wisely, experts say, when you pick your Medicare Part D prescription drug plan for 2025. What's in the formulary ...

In its complaint, the FTC accuses these companies of inflating insulin prices and steering ... as well as limitations on rebates, regulation of spread pricing, and other measures that would ...

While customers at Adams Family Pharmacy picked up their prescriptions on a hot summer day, some stopped in for coffee, ice ...

Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus, ...